Edarbi Tablet
Product Images NDC 60631-080

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Edarbi (NDC 60631-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Edarbi 01)

FDA Label Image

Figure 1 (Edarbi 02)

Figure 1 (Edarbi 02)
This is a population description for a study, including criteria for age, gender, race, and various impairments. It indicates whether or not dose adjustments are recommended based on fold changes and 90% CI, and notes when there is no experience with certain groups.*
FDA Label Image

Figure 2 (Edarbi 03)

Figure 2 (Edarbi 03)
This is a blood pressure monitoring study with readings for both diastolic and systolic pressure. The readings are given in mm Hg units. The study involved four groups: Edarbi80mg, Placebo, Olmesartan 40 mg, and Valsartan 320mg. The results are presented at different hours postdose.*
FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Principal Display Panel (40 mg Tablet Bottle Label)
NDC 60631-040-30 is a prescription medication known as Ayedarbi, containing azisartan medoxomil. Each container has 30 white tablets, and the typical dose is outlined in the package insert. The medication should be stored at room temperature, between 15-30°C, in its original container, protected from moisture and light. This medication is manufactured in Ireland by Arbor.*
FDA Label Image

Principal Display Panel (80 mg Tablet Bottle Label)

Principal Display Panel (80 mg Tablet Bottle Label)
This is a description of medication with the trade name "edarbi" which is available in tablet form. The tablets are packaged in bottles containing 30 tablets each. The package insert should be consulted for the usual dosage. The active ingredient in each white tablet is 85.36 mg azilsartan kamedoxomil, which is equivalent to 80 mg azilsartan medoxomil. The medication should be stored at room temperature with excursions allowed between 15-30°C (59-86°F) and protected from moisture and light. The medication is manufactured in Ireland and should not be repackaged or removed from the original container. The label contains a barcode and a serial number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.